Roivant Sciences Ltd (ROIV) Stock: A Year of Highs and Lows in the Market


Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Roivant Sciences Ltd’s current trading price is -19.03% away from its 52-week high, while its distance from the 52-week low is 30.02%. The stock’s price range over this period has fluctuated between $8.24 and $13.24. The company, operating within the financial sector, had a trading volume of approximately 4.75 million for the day, which was noticeably lower than the average daily share volume of 4.81 million over the last 3 months.

Roivant Sciences Ltd experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $13.24 on 09/28/23, while the lowest price for the same period was registered at $8.24 on 10/27/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Roivant Sciences Ltd (ROIV) has experienced a quarterly decline of -8.69% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.92B and boasts a workforce of 908 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 10.93, with a change in price of -0.15. Similarly, Roivant Sciences Ltd recorded 6,208,209 in trading volume during the last 100 days, posting a change of -1.38%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ROIV stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.08.

ROIV Stock Stochastic Average

Today, Roivant Sciences Ltd’s raw stochastic average for the past 50 days stands at 36.08%, indicating a decline from the raw stochastic average of the last 20 days, which was 61.04%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 47.62% and 39.39% respectively.

ROIV Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -4.54% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -0.92%. Over the past 30 days, the price of ROIV has leaped by -1.47%. And in the last five days, it has surged by 1.42%.

Most Popular